MD Insurance Bulletin 00-08
Contract Filings 00-08
Bulletin
DATE:
March 8, 2000
TO:
Small Group Insurance Companies
RE:
Contract Filings
Bulletin No: Life & Health 00-8
We would like to bring to your attention revisions that will be required of the small group
contracts issued or renewed on or after July 1, 2000. These revisions were published in the
Maryland Register on October 22, 1999. Notice of Final Action was published in the Maryland
Register on January 28, 2000.
We recommend that these changes be made through an amendment rider which will be
attached to the group policy and certificate. Please specify the form number and date of approval
of the policy to which the amendment rider will be attached. To ensure approval by July 1,
2000, the filings must be received by this Administration by May 1, 2000.
Revisions Required By COMAR 31.11.06
⦠New benefit for annual chlamydia screening test. See COMAR 31.11.06.03A(33).
⦠Prescription Drug Benefit
New requirement for Carriers to cover drugs through an open formulary, consisting of
generic, preferred brand-name, and non-preferred brand-name drugs. See COMAR
31.11.06.03E(2).
New exception to the cost sharing for persons enrolled in the PPO/MSA. Those enrollees
are not required to pay a $150 deductible separate from the deductibles set forth in
Regulation .04F. Instead, persons enrolled in PPO/MSA must only satisfy the deductible
set forth in COMAR 31.11.06.04F(6)(a) as a prerequisite to prescription drug benefits.
See COMAR 31.11.06.05H(1) and (2).
New three tier copayments for prescription drugs:
1. $15 for generic drugs;
2. $20 for preferred brand-name drugs; or
3. $30 for non-preferred brand-name drugs.
See COMAR 31.11.06.05H(3).
Regulation .04F. Instead, persons enrolled in PPO/MSA must only satisfy the deductible
set forth in COMAR 31.11.06.04F(6)(a) as a prerequisite to prescription drug benefits.
See COMAR 31.11.06.05H(1) and (2).
New three tier copayments for prescription drugs:
1. $15 for generic drugs;
2. $20 for preferred brand-name drugs; or
3. $30 for non-preferred brand-name drugs.
See COMAR 31.11.06.05H(3).
March 8, 2000
Page 2
Revised cost sharing for up to a 90-day supply of maintenance drugs dispensed in a
single dispensing of a prescription:
1. For generic maintenance drugs, one $30 copayment;
2. For preferred brand-name maintenance drugs, one $40 copayment; and
3. For non-preferred brand-name maintenance drugs, one $60 copayment.
See COMAR 31.11.06.05H(5).
Deleted the prohibition against a carrier reimbursing a health care practitioner in an
amount that is less than the cost to the practitioner for oncology drugs used in treating a
patient in the practitioner's office. See COMAR 31.11.06.03E(3).
⦠Cost Sharing ā Preferred Provider Delivery System
Increased the combined in-network and out-of-network deductible for employee enrolled
under individual coverage to $600 per year. Increased the combined in-network and outof-network deductible for employee enrolled under other than individual coverage to
$1200 in aggregate per year. See COMAR 31.11.06.04F(2)(a).
Increased the combined in-network and out-of-network out-of-pocket limit for employee
enrolled under individual coverage to $3400 per year. Increased the combined innetwork and out-of-network out-of-pocket limit for employee enrolled under other than
individual coverage to $6800 in aggregate per year. See COMAR 31.11.06.04F(2)(b).
⦠Smoking Cessation Exclusion
Modified Exclusion #39 to delete smoking cessation. Added new Exclusion #52 for
services related to smoking cessation. See COMAR 31.11.06.06B(39) and (52).
We are enclosing copies of the changes to the small group regulations published October 22,
1999
oyee enrolled under other than
individual coverage to $6800 in aggregate per year. See COMAR 31.11.06.04F(2)(b).
⦠Smoking Cessation Exclusion
Modified Exclusion #39 to delete smoking cessation. Added new Exclusion #52 for
services related to smoking cessation. See COMAR 31.11.06.06B(39) and (52).
We are enclosing copies of the changes to the small group regulations published October 22,
1999. Please note that the above summary does not include all changes to the regulations; it
details only the changes which are required by July 1, 2000. Changes that were required by
November 1, 1999 were detailed in Bulletin 99-18.
Please contact Fern Thomas, Supervisor, Health Review Unit at (410) 468-2170 if you have
any questions regarding these filings.
____________________________________
Donna B. Imhoff
Associate Commissioner